Although it remains unclear why TK1 is localized to the cell surface of multiple cancer cell lines, the flow cytometry data and ADCC results described here suggest that it could be feasible to harness the immune system against tumor cells expressing mTK1. Here, MAP3K4 is linked to neoplasm.